Table 3.
Adverse Events | Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
---|---|---|---|---|
Hematological AEs | ||||
Anemia | 16% | 3% | ||
Neutropenia | 11% | 5% | ||
Thrombocytopenia | 8% | |||
Lymphopenia | 3% | 3% | 3% | |
Non-Hematological AEs | ||||
Peripheral neuropathy | 49% | 3% | ||
AST elevation | 32% | 5% | 3% | |
ALT elevation | 27% | 11% | ||
Rash (new) | 24% | 11% | 5% | |
Muscle weakness | 24% | 5% | ||
Hypoglycemia | 22% | |||
Fatigue | 19% | 11% | ||
Pruritis | 19% | 3% | 3% | |
Nausea | 16% | 3% | ||
Abdominal Pain | 11% | 5% | ||
Creatinine elevated | 3% | |||
Tumor lysis syndrome | 3% | |||
Hyperuricemia | 3% |